Unknown

Dataset Information

Beta-Blocker Therapy Early After Myocardial Infarction: A Comparison Between Medication at Hospital Discharge and Subsequent Pharmacy-Dispensed Medication.


ABSTRACT:

Background

Beta-blocker (BB) therapy after myocardial infarction (MI) reduces all-cause mortality.

Objective

The aim of this study was to investigate BB dosing patterns and compliance following MI.

Methods

Using medical patient files and nationwide databases, we identified 100 patients who were discharged following MI in 2012 from Aarhus University Hospital, Denmark, and subsequently redeemed one or more BB prescriptions within 6 months. We obtained information about all BB medication prescribed at discharge and all BB prescriptions redeemed until 31 December 2013. Daily BB doses were computed as percentages of the target doses used in clinical trials documenting the efficacy of BBs after MI. Four dose groups were defined: ≤12.5, >12.5-25, >25-50, and >50 % of target

SUBMITTER: Pedersen SB 

PROVIDER: S-EPMC5042935 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature